-
to immigration timelines for non-EU candidates Number of Open Positions: 1 Pay: negotiable Application Deadline: 27.2.2026 EU Researcher Profile : R2/R3 About the Workplace Masaryk University is modern, dynamic
-
: The research group of prof. Michal Masařík is a biomedical laboratory dedicated to exploring the molecular mechanisms that drive cancer progression, with a particular emphasis on the tumour microenvironment (TME
-
research Medical Faculty of Masaryk University, Brno, Czech Republic invites excellent scientists to apply for a two-year POSTDOC POSITION in Computational Cancer Genomics Description: The position is
-
genome-wide analysis of the Czech/European population analyzed within the Genome of Europe project, which is currently underway in our laboratory. The successful candidate should: Hold a Ph.D. or its
-
of Masaryk University, Brno, Czech Republic invites excellent scientists to apply for a two-year POSTDOC POSITION in Cell Signaling Description: Postdoctoral position is available in laboratory of Pavel Krejci
-
Neurology at Masaryk University. The goal of our research group is to create robust computational frameworks with which to better understand how information is processed across the vast range of scales
-
integrity. A strong background in molecular or cellular biology, signalling pathways, or molecular cancer research. A prior experience with melanoma biology and MAPK signalling pathways is beneficial, but it
-
, or mechanotransduction signaling (e.g. YAP/TAZ, integrin, or intermediate-filament pathways) is advantageous. Ability to design and interpret experiments targeting the molecular determinants
-
are seeking a talented and motivated candidate to join our team to pursue the mechanisms and functions of primary cilia. The primary cilium is an antenna-like organelle that has emerged as a fundamental
-
well as bacteriophages infecting pathogenic bacteria. The Plevka Lab has access to cutting-edge cryo-EM equipment at our in-house core facility. Our work is supported by significant third-party funding, including an ERC